About

Pierre Bigot is a leading urologic oncologist whose research centers on the surgical management of kidney cancer, with a particular focus on nephron-sparing techniques. His landmark study, "Comparison of 1800 Robotic and Open Partial Nephrectomies for Renal Tumors" (179 citations), established him as a key voice in the debate between robotic-assisted and open surgical approaches. Through his leadership in the UroCCR national registry, Bigot has driven multiple large-scale, multicenter analyses that compare outcomes of robotic partial nephrectomy (RPN) against open surgery and percutaneous ablation, especially in challenging populations such as elderly patients over 75 and those with hilar tumors. His work on the NEPRAH study and the AblatT1b trial provides crucial evidence for tailoring treatment to tumor complexity and patient age. Bigot has also contributed to national clinical guidelines through the French AFU Cancer Committee, authoring the 2020–2024 updates on kidney cancer management. With over 400 citations across his most influential papers, his research directly informs clinical decision-making, helping surgeons and patients choose between robotic, open, and ablative therapies to maximize oncologic control while preserving renal function.

Research Focus

Key Achievements

11
H-Index
17
Papers
479
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of 1800 Robotic and Open Partial Nephrectomies for Renal Tumors
179 citations · 2016
📈 Most Prolific Year: 2023 (4 Papers)
🤝 Key Collaborators: 152
🏛 Institutions: Centre Hospitalier Universitaire de Toulouse, Centre Hospitalier Universitaire d'Angers, French Clinical Research Infrastructure Network, Université Paris Cité, Université d'Angers, Lymphoma Study Association

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago